Daily non-political popular news in brief.

Anti-obesity drug may prevent and treat obesity-related liver disease

07-02-2007 · EurekAlert!

A new study on the effect of the anti-obesity drug rimonabant on liver function in obese rats found that it reduced markers of liver damage, decreased levels of pro-inflammatory proteins, and improved lipid profiles.

Keywords: anti-obesity, drug, prevent, treat, obesity-related, liver, disease, anti, obesity, related

« Previous | Next »

Similar news on "Anti-obesity drug may prevent and treat obesity-related liver disease":

Incidence of Fatty Liver Disease rises as obesity in children increases
03-15-2007 · EurekAlert!
As part of a national multicenter research network, Indiana University School of Medicine researchers are looking at Vitamin E and at metformin, a drug used to treat Type II diabetes, as possible therapies for Fatty Liver Disease in 8 to 17 year olds. Fatty Liver Disease may exist in 15 percent or more of obese children.
Similar news · Read more »
Drug that lowers blood pressure might help prevent Alzheimer's disease
10-25-2007 · EurekAlert!
Alzheimer's disease is a neurodegenerative disease that is the most common form of dementia. Recent evidence indicates that some drugs used to treat high blood pressure might reduce the risk of developing AD. In a new study, the antihypertensive medication valsartan has been shown to reduce AD-like disease in mice.
Similar news · Read more »
Preclinical study suggests organ-transplant drug may aid in lupus fight
08-15-2007 · UT Southwestern Medical Center
A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.
Similar news · Read more »
University of Alberta researchers report breakthrough in lowering bad cholesterol, fatty acid levels
01-09-2008 · EurekAlert!
Medical researchers at the University of Alberta in Edmonton, Canada have found a way to reduce the amount of bad cholesterol and fatty acids that end up in the blood from food the body metabolizes, a key discovery that could lead to new drugs to treat and reverse the effects of diabetes and heart disease related to obesity. Existing drugs called statins are used to lower cholesterol, but do not treat obesity or diabetes.
Similar news · Read more »
Geisinger launches extensive study on obesity and related liver problem
04-16-2007 · EurekAlert!
Geisinger Health System researchers in Danville, Pa., are looking at the genetics of obesity through a unique study. Geisinger patients have voluntarily donated more than 600 liver tissue samples so that researchers can study obesity and also develop a safer, noninvasive way of detecting an obesity-related condition: nonalcoholic fatty liver disease. Relying on several core system resources in the study, Geisinger researchers hope to know more about nonalcoholic fatty liver disease and related health problems.
Similar news · Read more »
Quick-burning carbs may cause fatty liver
09-20-2007 · EurekAlert!
The obesity epidemic has spawned not just diabetes, but another serious public health problem: a surge in fatty liver disease, which can lead to cirrhosis and liver failure. Now, research suggests that limiting consumption of high-glycemic-index carbohydrates can prevent the condition in mice. A clinical trial is now testing this idea in overweight adolescents, as well as the possibility of reversing fatty liver disease through diet.
Similar news · Read more »
Fixes for Fatty Liver
03-03-2007 · Science News Online
A slate of experimental treatments, including three established diabetes drugs, could become medicines for nonalcoholic fatty liver disease, an obesity-related cause of cirrhosis.
Similar news · Read more »
Spotlight on liver disease: Improving today's treatments
05-20-2007 · EurekAlert!
Patients with liver disease often suffer from other related illnesses, including type-2 diabetes, obesity and high blood pressure, among others. Research presented today at Digestive Disease Week 2007 explores the many unknowns of liver disease by examining new liver biomarkers, understanding disease complications and assessing novel treatments for their disease-fighting potential. DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
Similar news · Read more »
Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese
11-01-2006 · EurekAlert!
Researchers have used a single compound to increase the lifespan of obese mice, and found that the drug reversed nearly all of the changes in gene expression patterns found in mice on high calorie diets -- some of which are associated with diabetes, heart disease and other significant diseases related to obesity. The research is the first time that the small molecule resveratrol has been shown to offer survival benefits in a mammal.
Similar news · Read more »
Anti-hypertensive drugs may help prevent and treat Alzheimer's disease
10-25-2007 · EurekAlert!
A new study has identified commonly prescribed drugs for the treatment of hypertension may be capable of preventing Alzheimer's disease and cognitive deterioration.
Similar news · Read more »